Padierna LJL

Language: Spanish
References: 27
Page: 278-283
PDF size: 176.77 Kb.

ABSTRACT

Introduction: Osteoporosis constitutes a high risk for fracture; if it involves hip, it imposes an important burden on a persons’ health because of its high morbidity, mortality and cost. In Mexico there are not enough studies on osteoporosis epidemiology, not for value of quantitative ultrasound of the calcaneus for its diagnosis.
Objective: To know the risk factors and prevalence of osteopenia and osteoporosis in women older than 40 years.
Patients and methods: A survey of women older than 40 years was done to identify risk factors and mineral bone density measured by quantitative ultrasound of the calcaneus. Association of risk factors with osteopenia and osteoporosis was established using χ2 test.
Results: 721 questionnaires were applied. Age average was 47 years. BMD was normal in 52.8% (n = 381); osteopenia was detected in 42.9% (n = 310) and osteoporosis in 4.16% (n = 30). Meaningfully associated risk factors (p < 0.05) with low mineral bone density were: age over 60 years old, history of fracture due to bone fragility, daily intake of more than four cups of coffee, 10 years or more of menopause, no hormonal therapy substitution.
Conclusions: Osteopenia prevalence in this study was similar to that reported in literature, but osteoporosis was slightly lower. Age above 60 years old was the risk factor mostly associated to low mineral bone density.

REFERENCES

1. Consensus development conference: diagnosis, prophylaxis and treatment of osteoporosis. Am J Med 1993;94(6):646-50.

2. NIH. Consensus development panel on osteoporosis prevention, diagnosis, and therapy. JAMA 2001;285(6):785-95.

3. Consenso Mexicano de Osteoporosis. Rev Invest Clin 2001;53(5):469-95.

4. Mendoza RMA, Escalante PJM, Martínez ZR, Ramírez AMC. Osteoporosis en mexicanas mayores de 40 años. Determinación por densitometría. Rev Med IMSS 2003;41(3):193-202.

5. Murillo UA, Delezé H, Aguirre E, Villa A y col. Osteoporosis en la mujer posmenopáusica mexicana. Magnitud del problema. Estudio Multicéntrico. Ginecol Obstet Mex 1999;67(5):227-33.

6. Riggs BL, Khosla S, Melton LJ. A unitary model for involutional osteoporosis: estrogen deficiency causes Type I and Type II osteoporosis in postmenopausal women and contributes to bone loss in aging men. J Bone Miner Res 1998;13:763-73.

7. Walker-Bone K, Walter G, Cooper C. Recent developments in the epidemiology of osteoporosis. Curr Opin Rheumatol 2002;14(4):411-5.

8. Dennison E, Cole Z, Cooper C. Diagnosis and epidemiology of osteoporosis. Curr Opin Rheumatol 2005;17(4):456-61.

9. WHO. Assessment of fracture risk and its application to screening for postmenopusal osteoporosis: Geneva: WHO, 1994.

10. Morales-Torres, Hernández OC, Alvarez CJA. Un análisis de actitudes y conocimientos sobre osteoporosis en médicos de primer contacto en León, Gto. Rev Endocrinol Nutr 2000;8(2):62-66.

11. Díaz-López JB, Gómez-Alonso C, Cannata Andía JB. Radiología de la fractura vertebral osteoporótica. Osteop Atenc Prim 1996;1:11-15.

12. Marshall D, Johnell O, Wedel H. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ 1996;312(7041):1254-9.

13. Greenspan SL, Cheng S, Miller PD, Orwoll ES. Clinical performance of a highly portable, scanning calcaneal ultrasonometer. Osteoporos Int 2001;12(5):391-8.

14. Nelson HD, Helfand M, Wolf SH, Allan JD, et al. Screening for postmenopausal osteoporosis: a review of the evidence for the U.S. Preventive Services Task Force. Ann Int Med 2002;137(6):529-41.

15. Osteoporosis postmenopáusica. Guía de práctica clínica. Grupo de trabajo de la Sociedad Española de Investigación Ósea y Metabolismo Mineral (SEIOMM). Rev Clin Esp 2003;203:496-506.

16. Frost ML, Blake GM, Fogelman I. Does quantitative ultrasound imaging enhance precision and discrimination? Osteoporos Int 2000;11(5):425-33,

17. Frost ML, Blake GM, Fogelman I. Can de WHO criteria for diagnosing osteoporosis be applied to calcaneal quantitative ultrasound? Osteoporos Int 2000;11(4):321-30.

18. Frost ML, Blake GM, Fogelman I. A comparison of fracture discrimination using calcaneal quantitative ultrasound and dual X-ray absorptiometry in women with a history of fracture at sites other than the spine and hip. Calcif Tissue Int 2002;71(3):207-11.

19. Falcini F, Hindi G, Ermini M, Poggi G, et al. Comparison of quantitative calcaneal ultrasound and dual energy Xray absorptiometry in the evaluation of osteoporotic risk in children with chronic rheumatic diseases. Calcif Tissue Int 2000;67(1):19-23.

20. Naganathan V, March L, Hunter D, Pocock NA, et al. Quantitative heel ultrasound as a predictor for osteoporosis. Med J Aust 1999;171:297-300.

21. Creer JR, Otter SJ, Bowen CJ. Use of quantitative ultrasound scans of the calcaneus to diagnose osteoporosis in patients with rheumatoid arthritis. J Am Podiatr Med Assoc 2007;97(2):108-14.

22. Díez-Pérez E, González-Macías J, Marín F, Abizanda M, et al. Prediction of absolute risk of non-spinal fractures using clinical risk factors and heel quantitative ultrasound. Osteoporos Int 2007;18(5):629-39.

23. Fujiwara S, Sone T, Yamazaki K, Yoshimura N, et al. Heel bone ultrasound predicts non-spine fracture in Japanese men and women. Osteoporos Int 2005;16(12):2107-12.

24. Khaw KT, Reeve J, Luben R, Bingham S, et al. Prediction of total and hip fracture risk in men and women by quantitative ultrasound of the calcaneus: EPIC-Norfolk prospective population study. Lancet 2004;363(9414):1076-7.

25. Kayak S, Olkin I, Grabe M, Gould MK, et al. Meta-analysis: accuracy of quantitative ultrasound for identifyin patients with osteoporosis. Ann Intern Med 2006;144:832-41.

26. Zárate A, Hernández M, Morán C, Angeles L. Enfoque moderno de la osteoporosis. Rev Fac Med UNAM 2003;46:49-51.

27. Diaz-Curiel M, García JJ, Carrasco JL, Honorato J, et al. Prevalencia de osteoporosis determinada por densitometría en la población femenina española. Med Clin Barc 2001;116: 86-88.